UM
Residential Collegefalse
Status已發表Published
S-adenosyl-L-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations
Taylor Levine, M.1; Gao, Jin2,3; Satyanarayanan, Senthil Kumaran4,5; Berman, Sarah1; Rogers, Jack T.2; Mischoulon, David1
2020-03-01
Source PublicationBrain, Behavior, and Immunity
ISSN0889-1591
Volume85Pages:152-161
Abstract

Given the limitations of prescription antidepressants, many individuals have turned to natural remedies for the management of their mood disorders. We review three selected natural remedies that may be of potential use as treatments for depressive disorders and other psychiatric or neurological conditions. The best studied and best supported of these three remedies is S-adenosyl-L-methionine (SAMe), a methyl donor with a wide range of physiological functions in the human organism. With the increasing legalization of cannabis-related products, cannabidiol (CBD) has gained popularity for various potential indications and has even obtained approval in the United States and Canada for certain neurological conditions. Kratom, while potentially useful for certain individuals with psychiatric disorders, is perhaps the most controversial of the three remedies, in view of its greater potential for abuse and dependence. For each remedy, we will review indications, doses and delivery systems, potential anti-inflammatory and immunomodulatory action, adverse effects, and will provide recommendations for clinicians who may be considering prescribing these remedies in their practice.

KeywordCannabidiol Cbd Kratom S-adenosyl-l-methionine Same
DOI10.1016/j.bbi.2019.07.013
URLView the original
Indexed BySCIE ; SSCI
Language英語English
WOS Research AreaImmunology ; Neurosciences & Neurology ; Psychiatry
WOS SubjectImmunology' Neurosciences ; Psychiatry
WOS IDWOS:000527886000016
Scopus ID2-s2.0-85068958747
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionUniversity of Macau
Corresponding AuthorMischoulon, David
Affiliation1.Depression Clinical and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, United States
2.Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, United States
3.Department of Clinical Psychology, Qilu Hospital of Shandong University, Qingdao, China
4.Department of Psychiatry & Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan
5.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao
Recommended Citation
GB/T 7714
Taylor Levine, M.,Gao, Jin,Satyanarayanan, Senthil Kumaran,et al. S-adenosyl-L-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations[J]. Brain, Behavior, and Immunity, 2020, 85, 152-161.
APA Taylor Levine, M.., Gao, Jin., Satyanarayanan, Senthil Kumaran., Berman, Sarah., Rogers, Jack T.., & Mischoulon, David (2020). S-adenosyl-L-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations. Brain, Behavior, and Immunity, 85, 152-161.
MLA Taylor Levine, M.,et al."S-adenosyl-L-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations".Brain, Behavior, and Immunity 85(2020):152-161.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Taylor Levine, M.]'s Articles
[Gao, Jin]'s Articles
[]'s Articles
Baidu academic
Similar articles in Baidu academic
[Taylor Levine, M.]'s Articles
[Gao, Jin]'s Articles
[Satyanarayanan,...]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Taylor Levine, M.]'s Articles
[Gao, Jin]'s Articles
[Satyanarayanan,...]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.